AGN 205728 is primarily utilized in the field of ophthalmology, specifically for its potential in treating eye conditions related to intraocular pressure. It is being researched for its efficacy in managing glaucoma, a condition characterized by increased pressure within the eye that can lead to optic nerve damage. The compound works by targeting specific pathways involved in the regulation of fluid dynamics within the eye, thereby helping to reduce intraocular pressure. Additionally, AGN 205728 is being explored for its potential use in other ocular disorders where pressure regulation is critical. Its application is still under investigation, with ongoing studies aimed at determining its safety, efficacy, and optimal dosing regimens for therapeutic use.